Developing next generation non-replicative HSV-1 vectors for sustainable and more precise gene therapies
Watch this webinar to learn how the challenges with using certain viral vectors in gene therapy has advanced the development of a new generation of precise vectors with sustainable effects. Our experts outline the limitations of existing vectors and how these can be overcome using modified recombinant non-replicative herpes simplex virus-1 (HSV-1) vectors. These vectors have potential to expand future applications for gene therapy.
Combining precision bispecific antibodies with targeted radiotherapy
By Alexander Schinagl (OncoOne)
Cell and gene therapy development moves into cardiac indications
By Ibon Garitaonandia (CellProthera)
Women in STEM with Gilda Ascione
By Gilda Ascione (Daiichi Sankyo Italy)
AI-driven drug discovery: insights from Cresset
By Dr Mutlu Dogruel (Cresset)
Beyond the lab: neuroscience
Download this free report to explore the future of neuroscience and current developments in drug discovery. It features interviews with experts discussing challenges and historical influences in the field, the role of neuroscientists in addressing environmental issues, and personal journeys in neuroscience.